Targeted Medical Stock Performance
| TRGM Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Targeted Medical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Targeted Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Targeted Medical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Targeted |
Targeted Medical Relative Risk vs. Return Landscape
If you would invest 0.01 in Targeted Medical on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Targeted Medical or generate 0.0% return on investment over 90 days. Targeted Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Targeted, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Targeted Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Targeted Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Targeted Medical, and traders can use it to determine the average amount a Targeted Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TRGM |
Based on monthly moving average Targeted Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Targeted Medical by adding Targeted Medical to a well-diversified portfolio.
Targeted Medical Fundamentals Growth
Targeted Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Targeted Medical, and Targeted Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Targeted Pink Sheet performance.
| Return On Asset | -0.48 | |||
| Profit Margin | (0.58) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 5.54 M | |||
| Shares Outstanding | 30.19 M | |||
| Price To Earning | (0.09) X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 5.26 M | |||
| EBITDA | (1.66 M) | |||
| Cash And Equivalents | 82.64 K | |||
| Total Debt | 670.9 K | |||
| Book Value Per Share | (0.47) X | |||
| Cash Flow From Operations | (1.28 M) | |||
| Earnings Per Share | (0.11) X | |||
| Total Asset | 2.43 M | |||
| Retained Earnings | (29.96 M) | |||
| Current Asset | 833 K | |||
| Current Liabilities | 14.68 M | |||
About Targeted Medical Performance
By examining Targeted Medical's fundamental ratios, stakeholders can obtain critical insights into Targeted Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Targeted Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California. Targeted Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 30 people.Things to note about Targeted Medical performance evaluation
Checking the ongoing alerts about Targeted Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Targeted Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Targeted Medical generated a negative expected return over the last 90 days | |
| Targeted Medical has some characteristics of a very speculative penny stock | |
| Targeted Medical has a very high chance of going through financial distress in the upcoming years | |
| Targeted Medical currently holds 670.9 K in liabilities. Targeted Medical has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Targeted Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Targeted Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Targeted Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Targeted to invest in growth at high rates of return. When we think about Targeted Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 5.26 M. Net Loss for the year was (3.04 M) with profit before overhead, payroll, taxes, and interest of 3.17 M. | |
| Targeted Medical currently holds about 82.64 K in cash with (1.28 M) of positive cash flow from operations. | |
| Roughly 62.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Targeted Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Targeted Medical's stock is overvalued or undervalued compared to its peers.
- Examining Targeted Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Targeted Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Targeted Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Targeted Medical's pink sheet. These opinions can provide insight into Targeted Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Targeted Pink Sheet
Targeted Medical financial ratios help investors to determine whether Targeted Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Targeted with respect to the benefits of owning Targeted Medical security.